Literature DB >> 2161040

High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.

T Kitamura1, Y Aso, N Kuniyoshi, K Hara, Y Yogo.   

Abstract

Urine specimens from 120 patients attending urologic clinics were screened by blot hybridization for the presence of a polyomavirus DNA. Detected viral DNA was then identified as BK or JC by fine restriction enzyme analysis. BK and JC viral DNA was found in 5 (4%) and 35 (29%) patients, respectively. Detection rates were compared among three age groups: 0-29, 30-59, and 60-89 years. Detection of JC viral DNA increased with age and reached the highest value (45%) in the group aged 60-89 years. For BK viral DNA a correlation between detection and age was not clear because the rate of detection was low, although the highest rate (9%) occurred in the oldest group. To confirm the active urinary excretion of polyomavirus DNA in older patients, urine specimens from 23 patients (60-90 years) treated at an internal medicine clinic were examined for viral DNA. BK and JC viral DNA were in 2 (9%) and 12 patients (52%), respectively. These results suggest that JC virus is frequently reactivated in older individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161040     DOI: 10.1093/infdis/161.6.1128

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

Review 1.  Convicting a human tumor virus: guilt by association?

Authors:  J A Blaho; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients.

Authors:  V Dubois; H Dutronc; M E Lafon; V Poinsot; J L Pellegrin; J M Ragnaud; A M Ferrer; H J Fleury
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Authors:  Xingxing S Cheng; Daniel L Bohl; Gregory A Storch; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Parmjeet Randhawa; Karen L Hardinger; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 4.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

5.  Typing of urinary JC virus DNA offers a novel means of tracing human migrations.

Authors:  C Sugimoto; T Kitamura; J Guo; M N Al-Ahdal; S N Shchelkunov; B Otova; P Ondrejka; J Y Chollet; S El-Safi; M Ettayebi; G Grésenguet; T Kocagöz; S Chaiyarasamee; K Z Thant; S Thein; K Moe; N Kobayashi; F Taguchi; Y Yogo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 6.  Polyomavirus BK infection in blood and marrow transplant recipients.

Authors:  L K Dropulic; R J Jones
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

7.  Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen.

Authors:  K Hara; C Sugimoto; T Kitamura; N Aoki; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Molecular analysis of JC virus genotypes circulating among the Italian healthy population.

Authors:  Elisabetta Pagani; Serena Delbue; Roberta Mancuso; Elisa Borghi; Letizia Tarantini; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

9.  Asian genotypes of JC virus in Japanese-Americans suggest familial transmission.

Authors:  Makoto Suzuki; Huai-Ying Zheng; Tomokazu Takasaka; Chie Sugimoto; Tadaichi Kitamura; Ernest Beutler; Yoshiaki Yogo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Diagnosis of childhood BK virus cystitis by electron microscopy and PCR.

Authors:  K Saitoh; N Sugae; N Koike; Y Akiyama; Y Iwamura; H Kimura
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.